<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01576263</url>
  </required_header>
  <id_info>
    <org_study_id>N-20090061</org_study_id>
    <nct_id>NCT01576263</nct_id>
  </id_info>
  <brief_title>Autologous Blood Transfusion After Local Infiltration</brief_title>
  <official_title>Autologous Blood Transfusion After Local Infiltration Analgesia With Ropivacaine in Total Knee and Hip Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northern Orthopaedic Division, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northern Orthopaedic Division, Denmark</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Total knee and hip arthroplasty for osteoarthritis is performed on still broader indications
      even in elderly patients with previous or current medical conditions. Especially comorbidity
      like cardiovascular diseases and conditions with increased risk of bleeding or previous
      thrombo-embolic events are major challenges.

      To facilitate safe use of ropivacaine as an analgesic, information on the concentrations
      levels after autologous blood transfusion following local infiltration analgesia is very
      crucial. However, very limited data are available. To verify the safety of autologous blood
      transfusion, ropivacaine concentrations were studied in 52 patients undergoing either total
      knee arthroplasty or total hip arthroplasty.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2010</start_date>
  <completion_date type="Actual">June 2010</completion_date>
  <primary_completion_date type="Actual">April 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Concentrations of ropivacaine in serum</measure>
    <time_frame>6 hours</time_frame>
    <description>Concentrations of ropivacaine in serum before and after autologous blood transfusion will be analyzed.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Analysis of ECG and pulse rate</measure>
    <time_frame>6 hours</time_frame>
    <description>ECG, pulse rate and blood pressure will be analyzed in proportion to concentrations of serum before and after autologous blood transfusion</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">52</enrollment>
  <condition>Total Hip Arthroplasty</condition>
  <condition>Total Knee Arthroplasty</condition>
  <arm_group>
    <arm_group_label>Total knee arthroplasty</arm_group_label>
    <description>25 consecutive patients diagnosed for total knee arthroplasty.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Total hip arthroplasty</arm_group_label>
    <description>27 patients diagnosed for total hip arthroplasty.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Autologous blood transfusion with ropivacaine</intervention_name>
    <description>Local infiltration analgesia with ropivacaine 3 mg/kg, max 200 mg</description>
    <arm_group_label>Total knee arthroplasty</arm_group_label>
    <other_name>No other names.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Autologous blood transfusion with ropivacaine</intervention_name>
    <description>Local infiltration analgesia with ropivacaine 3 mg/kg, max 200 mg.</description>
    <arm_group_label>Total hip arthroplasty</arm_group_label>
    <other_name>No other names.</other_name>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Venous blood to collect an analysis of total ropivacaine concentrations.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Primary care clinic.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis for hip arthroplasty

          -  Clinical diagnosis for knee arthroplasty

        Exclusion Criteria:

          -  Patients &lt; 18 years

          -  Lack of informed consent

          -  Inability to read/understand Danish

          -  Bilateral diagnosis

          -  Cancer diagnosis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ole Simonsen, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northern Orthopaedic Department, Aalborg University Hospital, Denmark</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sten Rasmussen, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Northern Orthopaedic Division, Aalborg University Hospital, Denmark</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bjarne B. Dencker, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Anaesthesiology, Aalborg University Hospital, Denmark</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Torben Breindahl, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Clinical Biochemistry, Vendsyssel Hospital, Aarhus University, Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Vendsyssel Hospital, Frederikshavn, Aalborg Hospital, Aarhus University</name>
      <address>
        <city>Aalborg</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 3, 2012</study_first_submitted>
  <study_first_submitted_qc>April 11, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 12, 2012</study_first_posted>
  <last_update_submitted>April 9, 2015</last_update_submitted>
  <last_update_submitted_qc>April 9, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 10, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Anaesthesia</keyword>
  <keyword>Infiltration</keyword>
  <keyword>Blood transfusion</keyword>
  <keyword>Autologous</keyword>
  <keyword>Arthroplasty</keyword>
  <keyword>Replacement</keyword>
  <keyword>Ropivacaine</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

